Class III · Lower riskActive recall
Sodium Iodide I-131
Unlikely to cause harm — often a labeling or packaging issue.
Does this affect you?
Check your lot numberLot, expiry: Lot 3666245, exp: 02/28/2026; Lot 4546213, exp: 02/28/2026 and Lot 4951280, exp 09/30/2027
Where it was soldNationwide in the US, including Puerto Rico
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Failed Tablet/Capsule Specifications
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byRadnostix, Inc.
| Brand name | SODIUM IODIDE I-131 |
| Generic name | SODIUM IODIDE I-131 |
| Distributed by / for | Radnostix |
| NDC | 69208-003-15 |
Show the full FDA record
| Full product label | Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing 5 empty capsules and 5 Dibasic Sodium Phosphate Capsules 300 mg, International Isotopes Inc., Idaho Falls, ID 83401. NDC: 69208-003-15; 69208-003-25; 69208-003-35 |
| Recalling firm | Radnostix |
| Distribution | Nationwide in the US, including Puerto Rico |
| Quantity | 2,699 blister cartons |
| Recall initiated | 2026-02-19 |
| Report date | 2026-04-01 |
| Recall completed | — |
| Recall number | D-0401-2026 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Idaho Falls ID United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.